Latest News & Updates
Early Agenda Now Available!
Get a first look at the key sessions and critical patent litigation issues shaping this year’s Conference.
View AgendaCall for Speakers
Have insights or expertise to share on drug access and reimbursement in Canada? We invite government, industry, payer, patient and other experts to join the conversation, share their perspectives and contribute to the 2027 program.
Apply NowThe Changing Pathway to Drug Access & Reimbursement in Canada
Prepare for the changes reshaping Canada’s pharmaceutical landscape, from new pricing pressures and government priorities to evolving payer expectations. CI’s Pathways to Drug Access & Reimbursement in Canada forum brings together government, pharmaceutical and life sciences companies, payers, patients, and other key stakeholders to discuss the policies and decisions influencing access to medicines.
Gain timely insights, exchange perspectives with industry leaders, and explore strategies to navigate change while balancing affordability, innovation, and patient access across Canada.
Advisory Board
Meet the distinguished Advisory Board guiding this year’s Forum. Bringing expertise from across the pharmaceutical and payer sectors, they ensure an agenda that drives meaningful dialogue on market access, reimbursement, and timely patient care.
View Advisory Board
Benefits to Attending
Build a stronger market access and reimbursement strategy
Gain a clearer view of Canada’s changing drug pricing landscape
Understand evolving payer, patient and health system priorities
Explore new approaches to evidence, value and patient access
Share ideas and connect with leaders across the drug-access community
Who You Will Meet
Practitioners at every level with experience in:
- Pricing
- Reimbursement
- Market access
- Patient access
- Government and regulatory affairs
- Health economics
- Research and development
- Policy and compliance
- Pharmacy services
- Marketing
- National trade
- Formularies
- Business development
- Sales
From brand generic and manufacturing companies involved in:
- Product development
- Public drug programs
- Pharmaceutical benefits
- Pharmaceutical strategy
- Drug submissions
- Formulary management
- Policy and economic analysis
- Provider services and relations
- Pharmacy
And representatives from:
- Associations
- Patient Advocacy Groups
Pre-Conference Virtual Workshops
Add more value to your conference experience by signing up for these hands-on and practical workshops and consider sending your team.
Virtual Workshop A
Keeping Canada in the Clinical Development Pipeline: Strengthening Evidence Generation and Market Access
March 2, 2027
9:00 am–12:00 pm
Virtual Workshop B
From Evidence to Reimbursement—Stress-Testing a Canadian HTA Submission
March 2, 2027
1:00–4:00 pm
Testimonials
“Great overview, gave me a different perspective. Got me thinking differently.”—Team Lead, Pricing and Contracts, GSK
“I liked the quality of the speakers.”—Manager, Market Access and HTA, BMS
“Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.”—Manager, Pricing and Contracts, Astellas
Sponsors & Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Lanny Morris
Senior Business Development Manager
Phone: 347-964-4766
Email: [email protected]